Exact Mass: 326.1256
Exact Mass Matches: 326.1256
Found 216 metabolites which its exact mass value is equals to given mass value 326.1256,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Neohesperidoside
Neohesperidoside, also known as 2-O-alpha-L-rhamnopyranosyl-D-glucopyranose or alpha-L-rhap-(1->2)-beta-D-glcp, is a member of the class of compounds known as O-glycosyl compounds. O-glycosyl compounds are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Neohesperidoside is soluble (in water) and a very weakly acidic compound (based on its pKa). Neohesperidoside can be found in lemon, which makes neohesperidoside a potential biomarker for the consumption of this food product. Neohesperidoside is the disaccharide which is present in some flavonoids. It can be found in species of typha, in species of typha angustifolia . Alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranose is a disaccharide consisting of alpha-L-rhamnose and beta-D-glucose linked via a 1->2 glycosidic bond. It has a role as a metabolite. 2-O-alpha-L-Rhamnopyranosyl-D-glucopyranose is a natural product found in Trypanosoma brucei with data available.
Clozapine
A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. [PubChem] N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 2841 CONFIDENCE standard compound; INTERNAL_ID 1600 Clozapine (HF 1854) is an antipsychotic used for the research of schizophrenia. Clozapine has high affinity for a number of neuroreceptors. Clozapine is a potent antagonist of dopamine D2 with a Ki of 75 nM. Clozapine inhibits the muscarinic M1 receptor and serotonin 5HT2A receptor with Kis of 9.5 nM and 4 nM, respectively[1][2][3]. Clozapine is also a potent and selective agonist at the muscarinic M4 receptor (EC50=11 nM)[4].
6,7-Dimethyl-8-(1-D-ribityl)lumazine
6,7-Dimethyl-8-(1-D-ribityl)lumazine belongs to the class of organic compounds known as pteridines and derivatives. These are polycyclic aromatic compounds containing a pteridine moiety, which consists of a pyrimidine fused to a pyrazine ring to form pyrimido(4,5-b)pyrazine. 6,7-Dimethyl-8-(1-D-ribityl)lumazine is an extremely weak basic (essentially neutral) compound (based on its pKa). 6,7-Dimethyl-8-(1-D-ribityl)lumazine exists in all living organisms, ranging from bacteria to humans. In humans, 6,7-dimethyl-8-(1-D-ribityl)lumazine is involved in riboflavin metabolism. Outside of the human body, 6,7-dimethyl-8-(1-D-ribityl)lumazine has been detected, but not quantified in, several different foods, such as quinoa, arrowhead, conchs, watermelons, and Elliotts blueberries. This could make 6,7-dimethyl-8-(1-D-ribityl)lumazine a potential biomarker for the consumption of these foods. 6,7-Dimethyl-8-(1-D-ribityl)lumazine is an intermediate in riboflavin metabolism. 6,7-Dimethyl-8-(1-D-ribityl)lumazine is the second to last step in the synthesis of ribitol and is converted from 4-(1-D-ribitylamino)-5-amino-2,6-dihydroxypyrimidine via the enzyme riboflavin synthase beta chain. It is then converted into riboflavin via the enzyme riboflavin synthase alpha chain (EC 2.5.1.9). 6,7-Dimethyl-8-(1-D-ribityl)lumazine is an intermediate in riboflavin metabolism. 6,7-Dimethyl-8-(1-D-ribityl)lumazine is the second to last step in the synthesis of ribitol and is converted from 4-(1-D-ribitylamino)-5-amino-2,6-dihydroxypyrimidine via the enzyme riboflavin synthase beta chain. It is then
2,2,4-Trimethyl-3-(4-fluorophenyl)-2H-1-benzopyran-7-ol acetate
3-O-alpha-D-glucopyranosyl-L-rhamnopyranose
Rutinose
Rutinose, also known as 6-O-(6-deoxy-alpha-L-mannopyranosyl)-D-glucose or (α-rhamnopyranosyl-β-glucopyranose, is a member of the class of compounds known as O-glycosyl compounds. O-glycosyl compounds are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Rutinose is soluble (in water) and a very weakly acidic compound (based on its pKa). Rutinose can be found in capers, which makes rutinose a potential biomarker for the consumption of this food product.
Neohesperidose
Neohesperidose is found in citrus. Neohesperidose occurs in plants as disaccharide component of
2-O-a-L-Fucopyranosyl-galactose
2-O-a-L-Fucopyranosyl-galactose is a disaccharide found in human breast milk that acts as an acceptor for N-acetylgalactosamine via alpha-galactosyltransferase activity (PMID:15158661).
3-O-a-L-Fucopyranosyl-D-glucose
3-O-alpha-L-Fucopyranosyl-D-glucose is a fucosylated oligosaccharide specific to human milk that form part of the innate immune system. contributing to the protection by breast-feeding of the newborn against enteric diseases through the mechanism of preventing the attachment of pathogenic bacteria to the duodenual epithelium. (PMID 1579031) [HMDB] 3-O-alpha-L-Fucopyranosyl-D-glucose is a fucosylated oligosaccharide specific to human milk that form part of the innate immune system. contributing to the protection by breast-feeding of the newborn against enteric diseases through the mechanism of preventing the attachment of pathogenic bacteria to the duodenual epithelium. (PMID 1579031).
6-O-b-D-Fructofuranosyl-2-deoxy-D-glucose
6-O-b-D-Fructofuranosyl-2-deoxy-D-glucose is found in brassicas. 6-O-b-D-Fructofuranosyl-2-deoxy-D-glucose is isolated from horseradish and peas which had been fed 2-deoxyglucose. Isolated from horseradish and peas which had been fed 2-deoxyglucose. 6-O-b-D-Fructofuranosyl-2-deoxy-D-glucose is found in brassicas and pulses.
Hydroxyhexamide
Hydroxyhexamide is a metabolite of acetohexamide. Acetohexamide (trade name Dymelor) is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone. (Wikipedia)
3-Hydroxydesloratadine
N-(N-Acetylmethionyl)dopamine
3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine
6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranose
Etomoxir
D007004 - Hypoglycemic Agents D004791 - Enzyme Inhibitors
(2R,3R,4S,5R)-2-(Hydroxymethyl)-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxane-3,4,5-triol
clozapine
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent CONFIDENCE standard compound; INTERNAL_ID 8610 CONFIDENCE standard compound; INTERNAL_ID 1600 Clozapine (HF 1854) is an antipsychotic used for the research of schizophrenia. Clozapine has high affinity for a number of neuroreceptors. Clozapine is a potent antagonist of dopamine D2 with a Ki of 75 nM. Clozapine inhibits the muscarinic M1 receptor and serotonin 5HT2A receptor with Kis of 9.5 nM and 4 nM, respectively[1][2][3]. Clozapine is also a potent and selective agonist at the muscarinic M4 receptor (EC50=11 nM)[4].
Me glycoside-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-mannose
Me glycoside-beta-Pyranose-2-O-beta-D-Glucopyranosyl-L-arabinose
Me glycoside-alpha-alpha-Furanose-2-O-beta-D-Glucopyranosyl-L-arabinose
1,6-(2-Oxoindoline-3,3-diyltrimethylene)-2-methyl-4(1H)-oxo-5,6-dihydronicotinic acid
3,4-dideoxy-6-O-alpha-D-galactopyranosyl-D-erythro-hexonic acid
methyl beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|Methyl ??-D-apiofuranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
4-Methylbenzenesulfonyl-(4R, 6S)-1, 7-Dioxaspiro[5.5]undecan-4-ol
2-deoxysucrose|2-Desoxy-alpha-D-glucopyranosyl-beta-D-fructofuranosid|2G-deoxysucrose
6beta-acetoxy-7alpha-chloroconfertifoline|7alpha-chloro-dihydrocinnamosmolide
2-O-alpha-D-Galactopyranosyl-L-rhamnose|2-O-beta-D-Galactopyranosyl-L-rhamnose|2-O-beta-D-Glucopyranosyl-L-rhamnose|alpha-Pryanose-form-2-O-alpha-D-Galactopyranosyl-L-rhamnose
scriptaid
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors
5H-Benzo[5,6]cyclohepta[1,2-b]pyridin-6-ol, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-
5-Hydroxy Desloratadine
2H-Benzo[5,6]cyclohepta[1,2-b]pyridin-2-one, 8-chloro-1,5,6,11-tetrahydro-11-(4-piperidinylidene)-
Gly Gly Gly His
Gly Gly His Gly
Gly His Gly Gly
His Gly Gly Gly
ethyl 5-amino-6-nitro-7-phenyl-2,3-dihydro-1H-indene-4-carboxylate
4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)-2-METHOXYANILINE
4-METHYL-2-[1-(TERT-BUTOXYCARBONYL)PIPERID-4-YL]-1,3-THIAZOLE-5-CARBOXYLIC ACID
7,7-dimethyl-3-[(3-nitrophenyl)methyl]-6,8-dihydro-1H-quinoline-2,5-dione
[7-(4-METHYLPIPERAZIN-1-YL)THIAZOLO[5,4-D]PYRIMIDIN-2-YL]PHENYLAMINE
L-745870
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants L-745870 is a potent, selective, brain-penetrant and orally active dopamine D4 receptor antagonist with a Ki of 0.43 nM. L-745870 shows weaker affinity for D2 (Ki of 960 nM) and D3 (Ki of 2300 nM) receptors, and exhibits moderate affinity for 5-HT2 receptors, sigma sites and α-adrenoceptors[1][2][3].
(-)-2,3-bis[(2R,5R)-2,5-dimethylphospholanyl]maleic anhydride
Ethyl 2-amino-7-isopropyl-5-oxo-5H-[1]-benzopyrano[2,3-b]pyridine-3-carboxylate
4-Benzenesulfonyl-piperazine-1-carboxylic acid tert-butyl ester
(S)-tert-Butyl 3-(2-fluoro-6-nitrophenoxy)pyrrolidine-1-carboxylate
Etomoxir
D007004 - Hypoglycemic Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor Etomoxir ((R)-(+)-Etomoxir) is an irreversible inhibitor of carnitine palmitoyltransferase 1a (CPT-1a), inhibits fatty acid oxidation (FAO) through CPT-1a and inhibits palmitate β-oxidation in human, rat and guinea pig.
2-Amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl ester 3-ethyl ester
ethyl 6-amino-5-cyano-4-(2,3-dihydro-1-benzofuran-5-yl)-2-methyl-4h-pyran-3-carboxylate
N-[4-(3-oxo-4-Morpholinyl)phenyl]carbaMic acid phenylMethyl ester
1-hexyl-2,3-dimethylimidazolium hexafluorophosphate
2-(4-Chloro-5-(cyclopropylmethoxy)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
3-[1-(2,3-DIMETHOXY-PHENYL)-2-NITRO-ETHYL]-1H-INDOLE
6-[(3,4,5-Trihydroxy-6-methyloxan-2-yl)oxymethyl]oxane-2,3,4,5-tetrol
2-O-(6-deoxy-alpha-L-galactopyranosyl)-D-galactopyranose
4-O-(beta-D-Galactopyranosyl)-alpha-L-rhamnopyranose
5-[(Z)-[5-[(E)-[5-[(Z)-pyrrol-2-ylidenemethyl]pyrrol-2-ylidene]methyl]pyrrol-2-ylidene]methyl]-1H-pyrrole-2-carbaldehyde
(2R,3R,4S,5R)-2-(Hydroxymethyl)-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxane-3,4,5-triol
4-[[5-Methyl-2-[3-(trifluoromethyl)phenyl]-4-oxazolyl]methyl]morpholine
alpha-L-rhamnopyranosyl-(1->2)-alpha-D-galactopyranose
2-(2-Furanyl)-3-(4-methylphenyl)imidazo[4,5-b]quinoxaline
2-Amino-1-(4-methylphenyl)-6-oxo-4-phenylpyridine-3,5-dicarbonitrile
N-(1,3-benzodioxol-5-yl)-3-[(2-methyl-1-oxopropyl)amino]benzamide
3-(2-methoxyphenyl)-2-methyl-4-oxo-1H-quinazoline-2-carboxylic acid methyl ester
(2Z)-N-(3-chlorophenyl)-2-(1,3,3-trimethylindol-2-ylidene)acetamide
[3)-alpha-L-Araf-(1->3)-6d-alpha-L-gulo-Hepp-(1->]n
2-(3-Benzoylphenyl)propionic acid trimethylsilyl ester
Dibenzo(D,F)-1,1,2,2,3,3-hexamethyl-1,2,3-trisilacyclohepta-4,6-diene
Neohesperidose
Alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranose is a disaccharide consisting of alpha-L-rhamnose and beta-D-glucose linked via a 1->2 glycosidic bond. It has a role as a metabolite. 2-O-alpha-L-Rhamnopyranosyl-D-glucopyranose is a natural product found in Trypanosoma brucei with data available. A disaccharide consisting of alpha-L-rhamnose and beta-D-glucose linked via a 1->2 glycosidic bond.
(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione
6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranose
Ethyl 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate
D007004 - Hypoglycemic Agents D004791 - Enzyme Inhibitors
alpha-L-Fucp-(1->3)-Glcp
A disaccharide that is D-glycopyranose in which the hydroxy group at position 3 has been converted into the corresponding alpha-L-fucoside.
alpha-L-Fucp-(1->6)-beta-D-Galp
An alpha-L-Fucp-(1->6)-D-Galp in which the carbon bearing the anomeric hydroxy group has beta configuration.
alpha-L-Fucp-(1->3)-alpha-D-Glcp
An alpha-L-Fucp-(1->3)-Glcp in which the carbon bearing the anomeric hydroxy group has alpha configuration.
alpha-L-Fucp-(1->2)-beta-D-Glcp
An alpha-L-Fucp-(1->2)-D-Glcp in which the carbon bearing the anomeric hydroxy group has beta configuration.
alpha-L-Fucp-(1->2)-alpha-D-Glcp
An alpha-L-Fucp-(1->2)-D-Glcp in which the carbon bearing the anomeric hydroxy group has alpha configuration.
cyclo(L-tyrosyl-L-tyrosyl)
A cyclo(tyrosyl-tyrosyl) in which both stereocentres have L-configuration. Synthesized by Mycobacterium tuberculosis.
alpha-L-Fucp-(1->2)-D-Glcp
A disaccharide that is D-glucopyranose in which the hydroxy group at position 2 has been converted into the corresponding alpha-L-fucopyranoside.
6,7-Dimethyl-8-(1-D-ribityl)lumazine
The pteridine that is lumazine substituted with methyl groups at C-6 and -7 and with a 1-D-ribityl group on N-8.
FAUC 213
FAUC 213 is an orally active and highly selective dopamine D4 receptor complete antagonist with a Ki of 2.2 nM for hD4.4. FAUC 213 has less activity on D2 and D3 receptors (Kis of 3.4 μM, 5.3 μM for hD2, hD3, respectively). FAUC 213 can cross the blood-brain barrier (BBB). FAUC 213 exhibits atypical antipsychotic characteristic[1].
(2r,3r,4r,5s,6s)-6-methyl-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2,3,5-triol
(3s,6s)-3,6-bis[(4-hydroxyphenyl)methyl]-3,6-dihydropyrazine-2,5-diol
(4s,5s,5as,9as)-4-chloro-6,6,9a-trimethyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate
4-hydroxy-6,7-dimethyl-8-(2,3,4,5-tetrahydroxypentyl)pteridin-2-one
3,6-di(4-hydroxy) benzyl-2,5-dioxopiperazine
{"Ingredient_id": "HBIN007707","Ingredient_name": "3,6-di(4-hydroxy) benzyl-2,5-dioxopiperazine","Alias": "3,6-di(4-hydroxy)benzyl-2,5-dioxopiperazine","Ingredient_formula": "C18H18N2O4","Ingredient_Smile": "C1=CC(=CC=C1CC2C(=O)NC(C(=O)N2)CC3=CC=C(C=C3)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15102","TCMID_id": "5769","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-o-(-l-fucopyranosyl-myo-inositol
{"Ingredient_id": "HBIN010773","Ingredient_name": "4-o-(-l-fucopyranosyl-myo-inositol","Alias": "NA","Ingredient_formula": "C12H22O10","Ingredient_Smile": "NA","Ingredient_weight": "326.3","OB_score": "NA","CAS_id": "99044-50-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7765","PubChem_id": "NA","DrugBank_id": "NA"}
